Novacyt SA
LSE:NCYT

Watchlist Manager
Novacyt SA Logo
Novacyt SA
LSE:NCYT
Watchlist
Price: 37.55 GBX -1.18% Market Closed
Market Cap: 26.5m GBX

Operating Margin
Novacyt SA

-69.9%
Current
-104%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-69.9%
=
Operating Profit
-13.4m
/
Revenue
19.1m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
FR
Novacyt SA
PAR:ALNOV
30.5m EUR
-70%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
402.4B USD
33%
US
Amgen Inc
NASDAQ:AMGN
178.1B USD
34%
US
Gilead Sciences Inc
NASDAQ:GILD
153.8B USD
39%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD
39%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82B USD
28%
AU
CSL Ltd
ASX:CSL
85.4B AUD
26%
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
54B USD
8%
NL
argenx SE
XBRU:ARGX
44.4B EUR
22%
No Stocks Found

Novacyt SA
Glance View

Market Cap
26.7m GBX
Industry
Biotechnology

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The firm provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The firm creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.

NCYT Intrinsic Value
54.03 GBX
Undervaluation 31%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-69.9%
=
Operating Profit
-13.4m
/
Revenue
19.1m
What is the Operating Margin of Novacyt SA?

Based on Novacyt SA's most recent financial statements, the company has Operating Margin of -69.9%.

Back to Top